BD Extends Leadership in Advanced Tissue Regeneration Through Continued Clinical Innovation
Go back to BD Extends Leadership in Advanced Tissue Regeneration Through Continued Clinical Innovation| Becton Dickinson (NYSE: BDX) | Delayed: 183.75 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $183.75 | 52 Week High | $181.76 | |||
| Open | $183.75 | 52 Week Low | $129.50 | |||
| Day High | $183.75 | P/E | 39.18 | |||
| Day Low | $183.75 | EPS | $4.69 | |||
| Volume | 1 | |||||



